Company page

Pulmatrix, Inc.

Pulmatrix, Inc. is a public company traded under the ticker PULM in the American market. With a market capitalization of approximately $5.33 million, Pulmatrix focuses on developing innovative therapies for respiratory diseases. The company aims to improve patient outcomes through its proprietary technologies and product candidates.